R. Ramos-medina, F. Moreno, S. Lopez-tarruella, S. Lopez-tarruella, D. Monte-millán et al., Review: circulating tumor cells in the practice of breast cancer oncology, Clinical and Translational Oncology, vol.31, issue.8, pp.749-59, 2016.
DOI : 10.1200/JCO.2013.50.9984

R. Paduch, The role of lymphangiogenesis and angiogenesis in tumor metastasis, Cellular Oncology, vol.13, issue.5, pp.397-410, 2016.
DOI : 10.1007/s11307-010-0366-1

F. Rovera, A. Fachinetti, S. Rausei, C. Chiappa, M. Lavazza et al., Prognostic role of micrometastases in sentinel lymph node in patients with invasive breast cancer, International Journal of Surgery, vol.11, issue.1, pp.73-78, 2013.
DOI : 10.1016/S1743-9191(13)60022-9

S. Stacker, M. Baldwin, and M. Achen, The role of tumor lymphangiogenesis in metastatic spread, The FASEB Journal, vol.16, issue.9, pp.922-956, 2002.
DOI : 10.1096/fj.01-0945rev

K. Alitalo, The lymphatic vasculature in disease, Nature Medicine, vol.16, issue.11, pp.1371-80, 2011.
DOI : 10.1158/1535-7163.MCT-09-0554

S. Stacker, S. Williams, T. Karnezis, R. Shayan, S. Fox et al., Lymphangiogenesis and lymphatic vessel remodelling in cancer, Nature Reviews Cancer, vol.66, issue.3, pp.159-72, 2014.
DOI : 10.1158/0008-5472.CAN-06-2977

B. Saffar, M. Bennett, C. Metcalf, and S. Burrows, Retrospective preoperative assessment of the axillary lymph nodes in patients with breast cancer and literature review, Clinical Radiology, vol.70, issue.9, pp.954-963, 2015.
DOI : 10.1016/j.crad.2015.04.019

L. Dieterich and M. Detmar, Tumor lymphangiogenesis and new drug development, Advanced Drug Delivery Reviews, vol.99, pp.148-60, 2016.
DOI : 10.1016/j.addr.2015.12.011

S. Ran, L. Volk, K. Hall, and M. Flister, Lymphangiogenesis and lymphatic metastasis in breast cancer, Pathophysiology, vol.17, issue.4, pp.229-51, 2010.
DOI : 10.1016/j.pathophys.2009.11.003

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2891887

J. Sleeman, The lymph node pre-metastatic niche, Journal of Molecular Medicine, vol.35, issue.Suppl 2, pp.1173-84, 2015.
DOI : 10.1016/j.biomaterials.2013.10.003

R. Kerbel, Reappraising antiangiogenic therapy for breast cancer, The Breast, vol.20, issue.3, pp.56-60, 2011.
DOI : 10.1016/S0960-9776(11)70295-8

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4540338

M. Martin, Understanding the value of antiangiogenic therapy in metastatic breast cancer, Current Opinion in Oncology, vol.23, p.1, 2011.
DOI : 10.1097/01.cco.0000397416.67622.10

M. Paez-ribes, E. Allen, J. Hudock, T. Takeda, H. Okuyama et al., Antiangiogenic Therapy Elicits Malignant Progression of Tumors to Increased Local Invasion and Distant Metastasis, Cancer Cell, vol.15, issue.3, pp.220-251, 2009.
DOI : 10.1016/j.ccr.2009.01.027

D. Ribatti, Antiangiogenic therapy accelerates tumor metastasis, Leukemia Research, vol.35, issue.1, pp.24-30, 2011.
DOI : 10.1016/j.leukres.2010.07.038

M. Saif, J. Knost, E. Chiorean, S. Kambhampati, D. Yu et al., Phase 1 study of the anti-vascular endothelial growth factor receptor 3 monoclonal antibody LY3022856/IMC-3C5 in patients with advanced and refractory solid tumors and advanced colorectal cancer, Cancer Chemotherapy and Pharmacology, vol.34, issue.11 Suppl, pp.815-839, 2016.
DOI : 10.3892/ijo_00000193

M. García-caballero, L. Cañedo, A. Fernández-medarde, M. Medina, and A. Quesada, The Marine Fungal Metabolite, AD0157, Inhibits Angiogenesis by Targeting the Akt Signaling Pathway, Marine Drugs, vol.1802, issue.1, pp.279-99, 2014.
DOI : 10.1083/jcb.66.2.451

N. Sounni, J. Cimino, S. Blacher, I. Primac, A. Truong et al., Blocking Lipid Synthesis Overcomes Tumor Regrowth and Metastasis after Antiangiogenic Therapy Withdrawal, Cell Metabolism, vol.20, issue.2, pp.280-94, 2014.
DOI : 10.1016/j.cmet.2014.05.022

URL : http://doi.org/10.1016/j.cmet.2014.05.022

B. Detry, S. Blacher, C. Erpicum, J. Paupert, L. Maertens et al., Sunitinib Inhibits Inflammatory Corneal Lymphangiogenesis, Investigative Opthalmology & Visual Science, vol.54, issue.5, pp.3082-93, 2013.
DOI : 10.1167/iovs.12-10856

URL : http://orbi.ulg.ac.be/bitstream/2268/151302/1/Detry%20B%202013.pdf

S. Blacher, B. Detry, F. Bruyère, J. Foidart, and A. Noël, Additional parameters for the morphometry of angiogenesis and lymphangiogenesis in corneal flat mounts, Experimental Eye Research, vol.89, issue.2, pp.274-76, 2009.
DOI : 10.1016/j.exer.2009.02.021

M. García-caballero, S. Blacher, J. Paupert, A. Quesada, M. Medina et al., Novel application assigned to toluquinol: inhibition of lymphangiogenesis by interfering with VEGF-C/VEGFR-3 signalling pathway, British Journal of Pharmacology, vol.74, issue.12, pp.1966-87, 2016.
DOI : 10.1016/j.mvr.2007.08.006

F. Bruyère, L. Melen-lamalle, S. Blacher, R. G. Thiry, M. Moons et al., Modeling lymphangiogenesis in a three-dimensional culture system, Nature Methods, vol.85, issue.5, pp.431-468, 2008.
DOI : 10.1007/BF02623576

R. Sweat, D. Sloas, and W. Murfee, VEGF-C Induces Lymphangiogenesis and Angiogenesis in the Rat Mesentery Culture Model, Microcirculation, vol.63, issue.6, pp.532-572, 2014.
DOI : 10.1002/jso.21714

B. Detry, C. Erpicum, J. Paupert, S. Blacher, C. Maillard et al., Matrix metalloproteinase-2 governs lymphatic vessel formation as an interstitial collagenase, Blood, vol.119, issue.21, pp.5048-56, 2012.
DOI : 10.1182/blood-2011-12-400267

S. Blacher, C. Erpicum, B. Lenoir, J. Paupert, G. Moraes et al., Cell Invasion in the Spheroid Sprouting Assay: A Spatial Organisation Analysis Adaptable to Cell Behaviour, PLoS ONE, vol.85, issue.5, p.97019, 2014.
DOI : 10.1371/journal.pone.0097019.t003

Y. Yoshimatsu, H. Miyazaki, and T. Watabe, Roles of signaling and transcriptional networks in pathological lymphangiogenesis, Advanced Drug Delivery Reviews, vol.99, pp.161-71, 2016.
DOI : 10.1016/j.addr.2016.01.020

M. Skobe, T. Hawighorst, D. Jackson, R. Prevo, L. Janes et al., Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis, Nature Medicine, vol.7, issue.2, pp.192-200, 2001.
DOI : 10.1038/84643

S. Mandriota, L. Jussila, M. Jeltsch, A. Compagni, D. Baetens et al., Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis, The EMBO Journal, vol.20, issue.4, pp.672-82, 2001.
DOI : 10.1093/emboj/20.4.672

URL : http://www.ncbi.nlm.nih.gov/pmc/articles/PMC145430

T. Karpanen, M. Egeblad, M. Karkkainen, H. Kubo, S. Ylä-herttuala et al., Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth, Cancer Res, vol.61, issue.5, pp.1786-90, 2001.

A. Timoshenko, C. Chakraborty, G. Wagner, and P. Lala, COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer, British Journal of Cancer, vol.59, issue.8, pp.1154-63, 2006.
DOI : 10.1016/j.lfs.2003.05.006

I. Tekedereli, S. Alpay, C. Tavares, Z. Cobanoglu, T. Kaoud et al., Targeted Silencing of Elongation Factor 2 Kinase Suppresses Growth and Sensitizes Tumors to Doxorubicin in an Orthotopic Model of Breast Cancer, PLoS ONE, vol.95, issue.7, p.41171, 2012.
DOI : 10.1371/journal.pone.0041171.s003

P. Cheng, W. Dai, F. Wang, J. Lu, M. Shen et al., Ethyl pyruvate inhibits proliferation and induces apoptosis of hepatocellular carcinoma via regulation of the HMGB1?RAGE and AKT pathways, Biochemical and Biophysical Research Communications, vol.443, issue.4, pp.1162-1170, 2014.
DOI : 10.1016/j.bbrc.2013.12.064

Y. He, K. Kozaki, T. Karpanen, K. Koshikawa, S. Yla-herttuala et al., Suppression of Tumor Lymphangiogenesis and Lymph Node Metastasis by Blocking Vascular Endothelial Growth Factor Receptor 3 Signaling, JNCI Journal of the National Cancer Institute, vol.94, issue.11, pp.819-844, 2002.
DOI : 10.1093/jnci/94.11.819

N. Roberts, B. Kloos, M. Cassella, S. Podgrabinska, K. Persaud et al., Inhibition of VEGFR-3 Activation with the Antagonistic Antibody More Potently Suppresses Lymph Node and Distant Metastases than Inactivation of VEGFR-2, Cancer Research, vol.66, issue.5, pp.2650-2657, 2006.
DOI : 10.1158/0008-5472.CAN-05-1843

J. Matsui, Y. Funahashi, T. Uenaka, T. Watanabe, A. Tsuruoka et al., Multi-Kinase Inhibitor E7080 Suppresses Lymph Node and Lung Metastases of Human Mammary Breast Tumor MDA-MB-231 via Inhibition of Vascular Endothelial Growth Factor-Receptor (VEGF-R) 2 and VEGF-R3 Kinase, Clinical Cancer Research, vol.14, issue.17, pp.5459-65, 2008.
DOI : 10.1158/1078-0432.CCR-07-5270

C. Heckman, T. Holopainen, M. Wirzenius, S. Keskitalo, M. Jeltsch et al., The Tyrosine Kinase Inhibitor Cediranib Blocks Ligand-Induced Vascular Endothelial Growth Factor Receptor-3 Activity and Lymphangiogenesis, Cancer Research, vol.68, issue.12, pp.4754-62, 2008.
DOI : 10.1158/0008-5472.CAN-07-5809

T. Schomber, A. Zumsteg, K. Strittmatter, I. Crnic, H. Antoniadis et al., Differential effects of the vascular endothelial growth factor receptor inhibitor PTK787/ZK222584 on tumor angiogenesis and tumor lymphangiogenesis, Molecular Cancer Therapeutics, vol.8, issue.1, pp.55-63, 2009.
DOI : 10.1158/1535-7163.MCT-08-0679

J. Burton, S. Priceman, J. Sung, E. Brakenhielm, D. An et al., Suppression of Prostate Cancer Nodal and Systemic Metastasis by Blockade of the Lymphangiogenic Axis, Cancer Research, vol.68, issue.19, pp.7828-7865, 2008.
DOI : 10.1158/0008-5472.CAN-08-1488

J. Yu, Y. Zhang, L. Leung, L. Liu, F. Yang et al., Efficacy and safety of angiogenesis inhibitors in advanced gastric cancer: a systematic review and meta-analysis, Journal of Hematology & Oncology, vol.95, issue.1, p.111, 2016.
DOI : 10.1016/j.critrevonc.2015.02.009

Y. Sun, W. Niu, F. Du, C. Du, S. Li et al., Safety, pharmacokinetics, and antitumor properties of anlotinib, an oral multi-target tyrosine kinase inhibitor, in patients with advanced refractory solid tumors, Journal of Hematology & Oncology, vol.92, issue.2, p.105, 2016.
DOI : 10.1016/j.critrevonc.2014.04.004

P. Rutkowski, E. Bylina, A. Klimczak, T. Switaj, S. Falkowski et al., The outcome and predictive factors of sunitinib therapy in advanced gastrointestinal stromal tumors (GIST) after imatinib failure - one institution study, BMC Cancer, vol.290, issue.4, p.107, 2012.
DOI : 10.1152/ajpheart.00133.2005

S. Zhang, Adjuvant sunitinib in renal-cell carcinoma, N Engl J Med, vol.376, issue.9, p.893, 2017.

C. Yeh, S. Wang, C. Tsai, Y. Chen, C. Liu et al., Surgical management of patients with progressing metastatic gastrointestinal stromal tumors receiving sunitinib treatment: A??prospective cohort study, International Journal of Surgery, vol.39, pp.30-36, 2017.
DOI : 10.1016/j.ijsu.2017.01.045